Eli Lilly & Co. (LLY)
NYSE · Manufacturing · Pharmaceutical preparations
$1,183.56+$1.67 (+0.14%) on the dayAs of the close; data may be delayed.
LLY price, last 12 months
Key stats
- Previous close
- $1,181.89
- Open
- $1,184.93
- Day range
- $1,160.84 – $1,190.00
- 52-week range
- $712.05 – $1,292.65
- Volume
- 1.5M
- Avg volume (20 days)
- 2.3M
- Market cap
- $1.0T
Performance
1W+2.7%
1M−0.5%
3M−2.0%
6M+32.0%
YTD+10.1%
1Y+59.5%
vs S&P 500, 1Y+42.8 pts
Technicals and fundamentals
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $1.0T